Ignite Creation Date:
2024-05-06 @ 1:05 PM
Last Modification Date:
2024-10-26 @ 1:08 PM
Study NCT ID:
NCT03929666
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-06
First Post:
2019-02-22
Brief Title:
A Safety and Efficacy Study of ZW25 Zanidatamab Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers Including Gastroesophageal Adenocarcinoma Biliary Tract Cancer and Colorectal Cancer
Sponsor:
Jazz Pharmaceuticals
Organization:
Jazz Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-29
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-22
First Submit QC Date:
April 23 2019
Study First Post Date:
2019-04-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-16
Last Update Post Date:
2024-06-06
Last Update Post Date Type:
ACTUAL